Skip to main content

More Treatments for All People More Quickly

We conduct research and support activities that address long-standing challenges in translational research so that new treatments and other health solutions reach people faster.

Latest News

Read our latest research news or follow coverage of our translational science activities through national and local media.

How Repurposing a Drug May Help Treat More Rare Gastrointestinal Diseases

June 29, 2026 - NCATS News

  • Rare Diseases Clinical Research Network (RDCRN)

RDCRN researchers found that dupilumab — a drug used for asthma and chronic obstructive pulmonary disease — shows promise in treating eosinophilic gastritis.

People With Chronic Back Pain May Be More Sensitive to Unpleasant Sounds

May 26, 2026 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Study finds people with chronic back pain may be more sensitive to unpleasant sounds, revealing sensory amplification that may be treatable.

FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder

May 21, 2026 - NCATS News

  • Our Impact on Clinical Trials
  • Our Impact on Drug Discovery and Development
  • Our Impact on Rare Diseases

MMA-101, an NIH-supported AAV gene therapy for a rare metabolic disorder, has received FDA clearance to begin clinical testing.


Featured Events

N3C logo
July NIH/NCATS N3C Community Forum

July 30, 2026 - Webinar

The National Clinical Cohort Collaborative (N3C) Community Forum will convene virtually on Thursday July 30, from 1 to 2 p.m. EDT. During the Forum, NCATS’ N3C Team will provide updates on the evolution of the platform and discuss the revised N3C Community Code of Conduct.

Please register today to join us on July 30 at 1 p.m. EDT.

Advancing Translational Science

Pediatrician listening to a child's heart with a stethoscope while sitting at a table with toys.

Our Impact

Learn how our work speeds research and improves health. Key areas include big data, clinical trials and rare diseases.

Scientist looks into a microscope with one scientist next to her and one behind her.

Research Activities

Explore our research labs, projects and collaborations that are advancing translational science. Our largest program is the Clinical and Translational Science Awards (CTSA) Program.

Two scientists look at lab equipment

Training & Education

Enhance your knowledge of translational science through programs, activities and resources offered by NCATS and our partner institutions.


Resources for You

Whether you're a researcher, an aspiring translational scientist or an interested member of the community, find information and materials important to you.


Director's Corner

Register for the NCATS Director Roundtable. December 3, 2025. 3:00–4:00 p.m. EST. National Center for Advancing Translational Sciences logo.
Upcoming Event

NCATS Director Roundtable

December 3, 2025

Supporters, researchers and educators will hear the latest updates from NCATS Director Dr. Rutter and can participate in an interactive discussion as we work together to bring more treatments to all people more quickly.

About the NCATS Director

Joni L. Rutter, Ph.D., is the director of NCATS at NIH. Rutter oversees the planning and execution of NCATS complex, multifaceted programs.

Previous Director's Messages

Search all Director's Messages by topic and year.

Subscribe to NCATS’ Community Update

Sign up to receive email messages from Dr. Rutter on center initiatives, input opportunities, events and other activities.

Last updated on July 9, 2026